(Q33275165)

25 July 2017

title

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations (English)

1 reference

25 July 2017

1 reference

7

Jos H Beijnen

1 reference

25 July 2017

3

John B A G Haanen

1 reference

25 July 2017

5

Jan H M Schellens

1 reference

25 July 2017

author name string

Judith Y M N Engwegen

1

1 reference

25 July 2017

Niven Mehra

2

1 reference

25 July 2017

Johannes M G Bonfrer

4

1 reference

25 July 2017

Emile E Voest

6

1 reference

25 July 2017

publication date

1 February 2007

1 reference

25 July 2017

published in

Laboratory Investigation

1 reference

25 July 2017

volume

87

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

161-172

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

25 July 2017

1 reference

7 January 2021

Protein biochips for differential profiling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Re: diagnostic potential of serum proteomic patterns in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Counterpoint: The vision for a new diagnostic paradigm

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Importance of communication between producers and consumers of publicly available experimental data

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

A data review and re-assessment of ovarian cancer serum proteomic profiling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Clarification in the point/counterpoint discussion related to surface-enhanced laser desorption/ionization time-of-flight mass spectrometric identification of patients with adenocarcinomas of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Serum biomarkers for detection of breast cancers: A prospective study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Classification of cancer types by measuring variants of host response proteins using SELDI serum assays

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Serum protein profile alterations in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Possible detection of pancreatic cancer by plasma protein profiling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Diagnostic potential of serum proteomic patterns in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

Serum protein profile analysis in patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700503

7 January 2021

10.1038/LABINVEST.3700503

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1011084951

0 references

1 reference